NASDAQ:ALDX

Aldeyra Therapeutics Stock Predictions

etoro logo Buy ALDX
*Your capital is at risk
$1.64
-0.0200 (-1.20%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

ALDX Prediction Chart

ALDX Predictions History

Latest community submissions for ALDX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 13, 2023 $10.82 +2.03% $10.39 X 95.81% 0
Jun 13, 2023 $10.74 +1.27% $10.39 X 96.59% 0
RKP RKP Senior
Jun 13, 2023 $11.33 +2.16% $10.39 X 90.95% 0
RKP RKP Senior
Jun 7, 2023 $11.12 -1.59% $11.48 X 96.86% 0
RKP RKP Senior
Jun 5, 2023 $10.82 +1.60% $11.35 V 95.33% 1
RKP RKP Senior
Jun 2, 2023 $10.80 +4.15% $10.65 V 98.59% 2
RKP RKP Senior
May 23, 2023 $9.65 -1.13% $9.82 X 98.27% 0
JS JS Pro
Apr 10, 2023 $9.99 +1.01% $10.33 V 96.71% 1
Apr 10, 2023 $9.69 -1.99% $10.33 X 93.84% 0
Apr 10, 2023 $9.77 -1.24% $10.33 X 94.55% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALDX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALDEYRA THERAPEUTICS
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE